Dergiler / KBB-Forum / 2020 / Cilt: 19 - Sayı: 1

MALIGN CERVICAL LYMPHADENOPATHY. WHOM AND WHERE?

Sayfa
126–132
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Apart from age and gender, we are in the opinion that the risk of malignancy increased by the enlargement of the size of cervical lymph nodes.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: Identification of specific characteristics of enlarged cervical lymph nodes could help the clinician for referring to surgical intervention in the diagnosis algorithm.
📊
Temel Bulgular & Veri:Material and Methods: Several factors such age, gender, lymph node size, anatomic location of lymph node was evaluated according to histopathology findings of the paediatric and adult patients between November 2014 and May 2019.
💡
Sonuç & Katkı:Apart from age and gender, we are in the opinion that the risk of malignancy increased by the enlargement of the size of cervical lymph nodes.
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Introduction: Identification of specific characteristics of enlarged cervical lymph nodes could help the clinician for referring to surgical intervention in the diagnosis algorithm. The main purpose of this research is to identify any possible relation between the malignancy and the risk factors at the cervical lymphadenopathy. Material and Methods: Several factors such age, gender, lymph node size, anatomic location of lymph node was evaluated according to histopathology findings of the paediatric and adult patients between November 2014 and May 2019. Results: The sizes of lymph nodes, anatomical location (supraclavicular region), adult age, male gender (adults) were the factors that found to be related to malignancy with a statistical significance. While the paediatric hypertrophic lymph node size was 1.5 cm and the adult lymph node size was 1.2 cm, the specificity rate for malignancy was 90% according to the biopsy results. Conclusion: The malignancy risk for a cervical lymph node may become higher at adult male patients and supraclavicular located ones. Apart from age and gender, we are in the opinion that the risk of malignancy increased by the enlargement of the size of cervical lymph nodes.

🔖

Bu Makaleye Atıf Yap

YAZICI, A., KANMAZ, M. A. (2020). MALIGN CERVICAL LYMPHADENOPATHY. WHOM AND WHERE?. KBB-Forum, Cilt: 19 - Sayı: 1, 126–132. https://ajindex.com/articles/164716

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Penn EB, Goudy SL. Pediatric inflammatory adenopathy. Otolaryngol Clin North Am. 2015
  2. 48(1):137-151. doi:10.1016/j.otc.2014.09.010 2.Leung AKC, Davies HD. Cervical lymphadenitis: Etiology, diagnosis, and management. Curr Infect Dis Rep. 2009
  3. 11(3):183-189. doi:10.1007/s11908-009-0028-0 3.Neff L, Newland JG, Sykes KJ, Selvarangan R, Wei JL. Microbiology and antimicrobial treatment of pediatric cervical lymphadenitis requiring surgical intervention. Int J Pediatr Otorhinolaryngol. 2013
  4. 77(5):817-820. doi:10.1016/J.IJPORL.2013.02.018 4.Deosthali A, Donches K, DelVecchio M, Aronoff S. Etiologies of Pediatric Cervical Lymphadenopathy: A Systematic Review of 2687 Subjects. Glob Pediatr Heal. 2019
  5. 2333794X1986544. doi:10.1177/2333794x19865440 5.Werner MT, Zhao C, Zhang Q, Wasik MA. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target. Blood. 2017
  6. 129(7):823-831. doi:10.1182/blood-2016-05-717793 6.Abadi U, Peled L, Gurion R, et al. Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma. Leuk Lymphoma. June 2019:1-5. doi:10.1080/10428194.2019.1620946 7.Fernández Aceñero MJ, Caso Viesca A, Díaz del Arco C. Role of fine needle aspiration cytology in the management of supraclavicular lymph node metastasis: Review of our experience. Diagn Cytopathol. 2019
  7. 47(3):181-186. doi:10.1002/dc.24064 8.Nasuti JF, Mehrotra R, Gupta PK. Diagnostic value of fine-needle aspiration in supraclavicular lymphadenopathy: A study of 106 patients and review of literature. Diagn Cytopathol. 2001
  8. 25(6):351-355. doi:10.1002/dc.10002 9.Matasar MJ, Zelenetz AD. Overview of lymphoma diagnosis and management. Radiol Clin North Am. 2008
  9. 46(2):175-198, vii. doi:10.1016/j.rcl.2008.03.005 10.Morris-Stiff G, Cheang P, Key S, Verghese A, Havard TJ. Does the surgeon still have a role to play in the diagnosis and management of lymphomas? World J Surg Oncol. 2008
  10. doi:10.1186/1477-7819-6-13 11.Hetemoğlu EK, Selim
  11. , Erbek S. PREDICTING MALIGNANCY IN CERVICAL LYMPH NODE: CLINICAL RESULTS. KBB-Forum. 2019
  12. 18(1):28-32. www.KBB-Forum.net. 12.Celenk F, Gulsen S, Elif Baysal ?, Aytac ? Ismail, Kul S, Kanlikama ? Muzaffer. Predictive factors for malignancy in patients with persistent cervical lymphadenopathy. Eur Arch Otorhinolaryngol. 2016
  13. :251-256. doi:10.1007/s00405-015-3717-3 13.Patra DK, Nath S, Biswas K, De J, Sarkar R. Diagnostic evaluation of childhood cervical lymphadenopathy by fine needle aspiration cytology. J